Text Size: A+| A-| A   |   Text Only Site   |   Accessibility
Department of Human Services

Influenza > H1N1 Vaccine

H1N1 Vaccine

On this page

Vaccine Resources
Provider Toolkit
Target Groups
Vaccine Implementation Subcommittee
Influenza Vaccine Information
Home Page
For Providers
H1N1 Vaccine Information
Influenza Surveillance 
Influenza Disease Information



H1N1 Vaccine Resources


  • Oregon Novel H1N1 Vaccination Planning Q & A - November 12, 2009 (pdf)

  • H1N1 Contact List (pdf) For providers: Who to contact in your community if you are interested in providing H1N1 vaccine (Updated November 9, 2009)

  • H1N1 Vaccine Approved (September 15, 2009)
    The U.S. Food and Drug Administration announced that it has approved four vaccines against the 2009 H1N1 influenza virus.

Provider Toolkit


Vaccine Distribution Vaccine Administration Ancillary Kit Information Vaccine Finance Dose Reporting
  • Guidelines for H1N1 Reporting (pdf) (September 22, 2009)
    This packet provides information on data submission to the ALERT Immunization Registry for provider sites enrolled to administer H1N1 vaccine. For additional information, contact ALERT Customer Service at 800-980-9431, or OHD.ALERT@STATE.OR.US
    • Scannable VAR Form and Ordering Instructions are in the guidelines
Vaccine Information

Initial Target Groups

When vaccine is first available, ACIP recommends that programs and providers administer vaccine to persons in the following five target groups (order of target groups does not indicate priority):


  • pregnant women,
  • persons who live with or provide care for infants aged
  • health-care and emergency medical services personnel,1
  • persons age 6 months--24 years, and
  • persons age 25--64 years who have medical conditions that put them at higher risk for influenza-related complications.2

These five target groups comprise an estimated 159 million persons in the United States. This estimate does not accurately account for persons who might be included in more than one category (e.g., a health-care worker with a high-risk condition). Vaccination programs and providers should begin vaccination of persons in all these groups as soon as vaccine is available.

1 Health-care personnel (HCP) include all paid and unpaid persons working in health-care settings who have the potential for exposure to patients with influenza, infectious materials, including body substances, contaminated medical supplies and equipment, or contaminated environmental surfaces. HCP might include (but are not limited to) physicians, nurses, nursing assistants, therapists, technicians, emergency medical service personnel, dental personnel, pharmacists, laboratory personnel, autopsy personnel, students and trainees, contractual staff not employed by the health-care facility, and persons (e.g., clerical, dietary, housekeeping, maintenance, and volunteers) not directly involved in patient care but potentially exposed to infectious agents that can be transmitted to and from HCP. The recommendations in this report apply to HCP in acute-care hospitals, nursing homes, skilled nursing facilities, physicians' offices, urgent care centers, and outpatient clinics, and to persons who provide home health care and emergency medical services (27). Emergency medical services personnel might include persons in an occupation (e.g., emergency medical technicians and fire fighters) who provide emergency medical care as part of their normal job duties.
2 Chronic medical conditions that confer a higher risk for influenza-related complications include chronic pulmonary (including asthma), cardiovascular (except hypertension), renal, hepatic, cognitive, neurologic/neuromuscular, hematologic, or metabolic disorders (including diabetes mellitus) or immunosuppression (including immunosuppression caused by medications or by human immunodeficiency virus) (12).


H1N1 Vaccine Implementation Sub-Committee


Final Charter


The DHS Immunization Policy Advisory Team Membership H1N1 Vaccine Implementation Subcommittee is chartered to address timely distributing, prioritizing and administering H1N1 vaccine in Oregon beginning in 2009. By bringing together representatives of immunization partner organizations, the Subcommittee will strategize; address key policy and implementation issues, and share ideas and best practices.


The Subcommittee will address all aspects of vaccine campaigns, including: planning scenario development; engaging vaccinators; vaccine ordering, allocation and distribution; vaccine administration reimbursement; monitoring and other overarching issues. The Subcommittee will gather and distribute information about federal and state policies and actions which will facilitate implementation of an H1N1 immunization program. Minutes from Subcommittee meetings/conference calls will be circulated to members and a wider audience including: local public health departments, tribes, state agencies, DHS Emergency Preparedness and Immunization Program staff. Member organizations will also circulate the minutes to their membership through their own channels.


The Subcommittee will address, as the issue arises, other medical countermeasures, including antivirals.



Sub-Committee Minutes

Tribes, Local Health Departments and State Agency Conference Call Minutes
 
Page updated: November 24, 2009

Click here to go to the Oregon Dept. of Veterans' Affairs outreach contact form

Get Adobe Acrobat ReaderAdobe Reader is required to view PDF files. Click the "Get Adobe Reader" image to get a free download of the reader from Adobe.